Published in FEBS Lett on September 26, 1994
Calcium and arrhythmogenesis. Physiol Rev (2007) 2.76
Reduced Ca2+ current, charge movement, and absence of Ca2+ transients in skeletal muscle deficient in dihydropyridine receptor beta 1 subunit. Biophys J (1996) 1.59
The beta subunit increases Ca2+ currents and gating charge movements of human cardiac L-type Ca2+ channels. Biophys J (1996) 1.24
Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proc Natl Acad Sci U S A (1998) 1.09
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Diversity and developmental expression of L-type calcium channel beta2 proteins and their influence on calcium current in murine heart. J Biol Chem (2009) 1.01
Dihydropyridine enantiomers block recombinant L-type Ca2+ channels by two different mechanisms. J Physiol (1999) 0.87
Molecular basis of drug interaction with L-type Ca2+ channels. J Bioenerg Biomembr (1998) 0.85
Microdomain-specific localization of functional ion channels in cardiomyocytes: an emerging concept of local regulation and remodelling. Biophys Rev (2015) 0.75
Glycoproteins of cell surfaces. A comparative study of three different cell surfaces of the rat. J Biol Chem (1971) 5.25
Congenital deafness and sinoatrial node dysfunction in mice lacking class D L-type Ca2+ channels. Cell (2000) 5.08
Molecular weight determination of membrane protein and glycoprotein subunits by discontinuous gel electrophoresis in dodecyl sulfate. Methods Enzymol (1974) 3.50
Purification, molecular cloning, and expression of the mammalian sigma1-binding site. Proc Natl Acad Sci U S A (1996) 3.39
alpha 1D (Cav1.3) subunits can form l-type Ca2+ channels activating at negative voltages. J Biol Chem (2001) 2.77
Mutations in the Delta7-sterol reductase gene in patients with the Smith-Lemli-Opitz syndrome. Proc Natl Acad Sci U S A (1998) 2.22
Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem (2000) 2.09
Receptor sites for Ca2+ channel antagonists. Trends Pharmacol Sci (1992) 1.84
Fast exocytosis with few Ca(2+) channels in insulin-secreting mouse pancreatic B cells. Biophys J (2001) 1.79
Plasma membrane protein subunit composition. A comparative study by discontinuous electrophoresis in sodium dodecyl sulfate. J Biol Chem (1971) 1.74
Distribution of high-conductance Ca(2+)-activated K+ channels in rat brain: targeting to axons and nerve terminals. J Neurosci (1996) 1.71
Structural basis of drug binding to L Ca2+ channels. Trends Pharmacol Sci (1998) 1.69
Mutational spectrum in the Delta7-sterol reductase gene and genotype-phenotype correlation in 84 patients with Smith-Lemli-Opitz syndrome. Am J Hum Genet (2000) 1.61
Assay for calcium channels. Methods Enzymol (1985) 1.60
Visualization of the domain structure of an L-type Ca2+ channel using electron cryo-microscopy. J Mol Biol (2003) 1.56
7-Dehydrocholesterol-dependent proteolysis of HMG-CoA reductase suppresses sterol biosynthesis in a mouse model of Smith-Lemli-Opitz/RSH syndrome. J Clin Invest (2001) 1.55
Molecular cloning and expression of the human delta7-sterol reductase. Proc Natl Acad Sci U S A (1998) 1.49
Mutations in the gene encoding 3 beta-hydroxysteroid-delta 8, delta 7-isomerase cause X-linked dominant Conradi-Hünermann syndrome. Nat Genet (1999) 1.47
Transfer of 1,4-dihydropyridine sensitivity from L-type to class A (BI) calcium channels. Neuron (1996) 1.46
Current modulation and membrane targeting of the calcium channel alpha1C subunit are independent functions of the beta subunit. J Physiol (1999) 1.45
Familial hemiplegic migraine mutations change alpha1A Ca2+ channel kinetics. J Biol Chem (1998) 1.44
Molecular properties of calcium channels. Rev Physiol Biochem Pharmacol (1990) 1.44
Use of unlicensed nitric oxide in Austria. Lancet (1997) 1.38
Excitation-contraction coupling is unaffected by drastic alteration of the sequence surrounding residues L720-L764 of the alpha 1S II-III loop. Proc Natl Acad Sci U S A (2001) 1.37
Evidence of multiple receptor sites within the putative calcium channel. Naunyn Schmiedebergs Arch Pharmacol (1982) 1.37
The triad targeting signal of the skeletal muscle calcium channel is localized in the COOH terminus of the alpha(1S) subunit. J Cell Biol (2000) 1.32
Identification of 1,4-dihydropyridine binding regions within the alpha 1 subunit of skeletal muscle Ca2+ channels by photoaffinity labeling with diazipine. Proc Natl Acad Sci U S A (1991) 1.31
Endogenous calcium channels in human embryonic kidney (HEK293) cells. Br J Pharmacol (1996) 1.31
Purified skeletal muscle 1,4-dihydropyridine receptor forms phosphorylation-dependent oligomeric calcium channels in planar bilayers. Proc Natl Acad Sci U S A (1988) 1.28
(+)-Niguldipine binds with very high affinity to Ca2+ channels and to a subtype of alpha 1-adrenoceptors. Eur J Pharmacol (1989) 1.28
Beta subunit heterogeneity in neuronal L-type Ca2+ channels. J Biol Chem (1997) 1.27
Properties of angiotensin II receptors in the bovine and rat adrenal cortex. J Biol Chem (1974) 1.25
Identification of a novel 1,4-dihydropyridine- and phenylalkylamine-binding polypeptide in calcium channel preparations. J Biol Chem (1987) 1.25
Binding of 3 H-desmethylphalloin to isolated plasma membranes from rat liver. Naunyn Schmiedebergs Arch Pharmacol (1972) 1.21
High affinity of sigma 1-binding sites for sterol isomerization inhibitors: evidence for a pharmacological relationship with the yeast sterol C8-C7 isomerase. Br J Pharmacol (1997) 1.20
Differential effects of Ca2+ channel beta1a and beta2a subunits on complex formation with alpha1S and on current expression in tsA201 cells. J Biol Chem (1998) 1.19
Down-regulation of L-type calcium channels in inflamed circular smooth muscle cells of the canine colon. Gastroenterology (2001) 1.18
Calcium channels from Cyprinus carpio skeletal muscle. Proc Natl Acad Sci U S A (1991) 1.17
Solubilization and partial purification of putative calcium channels labelled with [3H]-nimodipine. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.17
Angiotensin II receptors in bovine adrenal cortex. Modification of angiotensin II binding by guanyl nucleotides. J Biol Chem (1974) 1.14
Neurological phenotype and synaptic function in mice lacking the CaV1.3 alpha subunit of neuronal L-type voltage-dependent Ca2+ channels. Neuroscience (2003) 1.13
Identification of a phenylalkylamine binding region within the alpha 1 subunit of skeletal muscle Ca2+ channels. Proc Natl Acad Sci U S A (1990) 1.13
Photoaffinity labelling of the phenylalkylamine receptor of the skeletal muscle transverse-tubule calcium channel. FEBS Lett (1987) 1.13
Purification of the putative calcium channel from skeletal muscle with the aid of [3H]-nimodipine binding. Naunyn Schmiedebergs Arch Pharmacol (1983) 1.13
L-type calcium channels in insulin-secreting cells: biochemical characterization and phosphorylation in RINm5F cells. Mol Endocrinol (1997) 1.12
Three new familial hemiplegic migraine mutants affect P/Q-type Ca(2+) channel kinetics. J Biol Chem (2000) 1.12
Stereoselective photoaffinity labelling of the purified 1,4-dihydropyridine receptor of the voltage-dependent calcium channel. Eur J Biochem (1986) 1.12
Phenylalkylamine Ca2+ antagonist binding protein. Molecular cloning, tissue distribution, and heterologous expression. J Biol Chem (1995) 1.12
Identification of PK-A phosphorylation sites in the carboxyl terminus of L-type calcium channel alpha 1 subunits. Biochemistry (1996) 1.11
(-)-[3H]Desmethoxyverapamil, a novel Ca2+ channel probe. Binding characteristics and target size analysis of its receptor in skeletal muscle. FEBS Lett (1984) 1.11
Transfer of high sensitivity for benzothiazepines from L-type to class A (BI) calcium channels. J Biol Chem (1996) 1.10
Association of calcium channel alpha1S and beta1a subunits is required for the targeting of beta1a but not of alpha1S into skeletal muscle triads. Proc Natl Acad Sci U S A (1998) 1.09
Analysis of membrane protein self-association in lipid systems by fluorescence particle counting: application to the dihydropyridine receptor. Biochemistry (1997) 1.08
The mysteries of sigma receptors: new family members reveal a role in cholesterol synthesis. Trends Pharmacol Sci (1997) 1.07
Renal receptors for calcitonin. Binding and degradation of hormone. J Biol Chem (1973) 1.06
Conserved Ca2+-antagonist-binding properties and putative folding structure of a recombinant high-affinity dihydropyridine-binding domain. Biochem J (2000) 1.06
Photoaffinity labelling of Ca2+ channels with [3H]azidopine. FEBS Lett (1984) 1.03
Nine L-type amino acid residues confer full 1,4-dihydropyridine sensitivity to the neuronal calcium channel alpha1A subunit. Role of L-type Met1188. J Biol Chem (1997) 1.02
Identification of a 27-kDa high affinity phenylalkylamine-binding polypeptide as the sigma 1 binding site by photoaffinity labeling and ligand-directed antibodies. Mol Pharmacol (1993) 1.02
Up-regulation of dopamine D(2)L mRNA levels in the ventral tegmental area and dorsal striatum of amphetamine-sensitized C57BL/6 mice: role of Ca(v)1.3 L-type Ca(2+) channels. J Neurochem (2006) 1.01
Molecular mechanism of use-dependent calcium channel block by phenylalkylamines: role of inactivation. Proc Natl Acad Sci U S A (1997) 1.00
Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.99
Solid phase radioimmunoassay for cyclic AMP using staphylococcal protein A-antibody adsorbent. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.98
Genetic defects in postsqualene cholesterol biosynthesis. Trends Endocrinol Metab (2000) 0.98
Brain activation pattern induced by stimulation of L-type Ca2+-channels: contribution of Ca(V)1.3 and Ca(V)1.2 isoforms. Neuroscience (2006) 0.98
High affinity interaction of mibefradil with voltage-gated calcium and sodium channels. Br J Pharmacol (2000) 0.97
Calcium channels and calcium channel drugs: recent biochemical and biophysical findings. Arzneimittelforschung (1985) 0.96